Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve With reference to the above ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gennex Laboratories Ltd has scheduled a board meeting on May 30, 2026 at 4:00 PM to consider and adopt the Audited Financial Statements (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026. The meeting will also review the Independent Reports of the Statutory Auditor on both standalone and consolidated financials. The company has confirmed that the trading window, which was closed from April 1, 2026, will reopen 48 hours after the declaration of these audited financial results. This is a routine compliance filing under SEBI LODR Regulations.
The announcement signals that Q4 and full-year FY 2026 results are pending, which could trigger volatility in the stock price around the results declaration date. Investors should watch for the results announcement expected shortly after May 30, 2026.